» Articles » PMID: 24831005

Tyrosine 308 is Necessary for Ligand-directed Gs Protein-biased Signaling of β2-adrenoceptor

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2014 May 17
PMID 24831005
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Interaction of a given G protein-coupled receptor to multiple different G proteins is a widespread phenomenon. For instance, β2-adrenoceptor (β2-AR) couples dually to Gs and Gi proteins. Previous studies have shown that cAMP-dependent protein kinase (PKA)-mediated phosphorylation of β2-AR causes a switch in receptor coupling from Gs to Gi. More recent studies have demonstrated that phosphorylation of β2-AR by G protein-coupled receptor kinases, particularly GRK2, markedly enhances the Gi coupling. We have previously shown that although most β2-AR agonists cause both Gs and Gi activation, (R,R')-fenoterol preferentially activates β2-AR-Gs signaling. However, the structural basis for this functional selectivity remains elusive. Here, using docking simulation and site-directed mutagenesis, we defined Tyr-308 as the key amino acid residue on β2-AR essential for Gs-biased signaling. Following stimulation with a β2-AR-Gs-biased agonist (R,R')-4'-aminofenoterol, the Gi disruptor pertussis toxin produced no effects on the receptor-mediated ERK phosphorylation in HEK293 cells nor on the contractile response in cardiomyocytes expressing the wild-type β2-AR. Interestingly, Y308F substitution on β2-AR enabled (R,R')-4'-aminofenoterol to activate Gi and to produce these responses in a pertussis toxin-sensitive manner without altering β2-AR phosphorylation by PKA or G protein-coupled receptor kinases. These results indicate that, in addition to the phosphorylation status, the intrinsic structural feature of β2-AR plays a crucial role in the receptor coupling selectivity to G proteins. We conclude that specific interactions between the ligand and the Tyr-308 residue of β2-AR stabilize receptor conformations favoring the receptor-Gs protein coupling and subsequently result in Gs-biased agonism.

Citing Articles

Molecular Modeling Study of a Receptor-Orthosteric Ligand-Allosteric Modulator Signaling Complex.

Jiang C, He X, Wang Y, Chen C, Othman Y, Hao Y ACS Chem Neurosci. 2023; 14(3):418-434.

PMID: 36692197 PMC: 10032570. DOI: 10.1021/acschemneuro.2c00554.


Tyrosine 7.43 is important for mu-opioid receptor downstream signaling pathways activated by fentanyl.

Tian X, Zhang J, Wang S, Gao H, Sun Y, Liu X Front Pharmacol. 2022; 13:919325.

PMID: 36120357 PMC: 9478952. DOI: 10.3389/fphar.2022.919325.


Ligands of Adrenergic Receptors: A Structural Point of View.

Wu Y, Zeng L, Zhao S Biomolecules. 2021; 11(7).

PMID: 34202543 PMC: 8301793. DOI: 10.3390/biom11070936.


Structural Insights into Ligand-Receptor Interactions Involved in Biased Agonism of G-Protein Coupled Receptors.

Jozwiak K, Plazinska A Molecules. 2021; 26(4).

PMID: 33561962 PMC: 7915493. DOI: 10.3390/molecules26040851.


Receptor-Arrestin Interactions: The GPCR Perspective.

Seyedabadi M, Gharghabi M, Gurevich E, Gurevich V Biomolecules. 2021; 11(2).

PMID: 33557162 PMC: 7913897. DOI: 10.3390/biom11020218.


References
1.
Nygaard R, Zou Y, Dror R, Mildorf T, Arlow D, Manglik A . The dynamic process of β(2)-adrenergic receptor activation. Cell. 2013; 152(3):532-42. PMC: 3586676. DOI: 10.1016/j.cell.2013.01.008. View

2.
Plazinska A, Kolinski M, Wainer I, Jozwiak K . Molecular interactions between fenoterol stereoisomers and derivatives and the β₂-adrenergic receptor binding site studied by docking and molecular dynamics simulations. J Mol Model. 2013; 19(11):4919-30. PMC: 3825559. DOI: 10.1007/s00894-013-1981-y. View

3.
Kobilka B . Structural insights into adrenergic receptor function and pharmacology. Trends Pharmacol Sci. 2011; 32(4):213-8. PMC: 3090711. DOI: 10.1016/j.tips.2011.02.005. View

4.
Lefkowitz R, Pierce K, Luttrell L . Dancing with different partners: protein kinase a phosphorylation of seven membrane-spanning receptors regulates their G protein-coupling specificity. Mol Pharmacol. 2002; 62(5):971-4. DOI: 10.1124/mol.62.5.971. View

5.
Schmitt J, Stork P . beta 2-adrenergic receptor activates extracellular signal-regulated kinases (ERKs) via the small G protein rap1 and the serine/threonine kinase B-Raf. J Biol Chem. 2000; 275(33):25342-50. DOI: 10.1074/jbc.M003213200. View